Myriad Genetics, Inc. (MYGN)

Myriad Genetics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jun 30, 2020	Jun 30, 2019
Market Capitalization	2,350	1,573	1,176	2,204	845	2,038
Market Cap Growth	1.55%	33.80%	-46.65%	160.69%	-58.52%	-21.98%
Enterprise Value	2,393	1,584	1,206	1,957	922	2,135
PE Ratio	-	-5.97	-10.50	-81.03	-4.24	443.11
PS Ratio	3.04	2.09	1.73	3.19	1.32	2.40
PB Ratio	3.09	2.01	1.33	2.28	0.92	1.87
P/FCF Ratio	-12.39	-8.54	-7.76	3673.31	16.74	27.14
P/OCF Ratio	-19.90	-14.19	-11.06	118.49	13.93	24.35
EV/Sales Ratio	3.09	2.10	1.78	2.83	1.44	2.51
EV/EBITDA Ratio	-11.96	-8.51	-16.52	77.99	-6.57	25.06
EV/EBIT Ratio	-8.42	-6.11	-8.78	-38.76	-4.34	174.99
EV/FCF Ratio	-12.66	-8.60	-7.95	3262.48	18.27	28.43
Debt / Equity Ratio	0.19	0.19	0.16	0.10	0.32	0.21
Debt / EBITDA Ratio	-0.90	-0.82	-1.99	3.68	-2.10	2.74
Debt / FCF Ratio	-0.95	-0.83	-0.96	153.83	5.84	3.11
Quick Ratio	1.52	1.64	1.58	2.11	1.96	2.34
Current Ratio	1.99	2.01	2.00	2.37	2.26	2.96
Asset Turnover	0.67	0.65	0.56	0.52	0.42	0.55
Interest Coverage	-80.21	-89.41	-42.94	-7.65	-19.67	1.02
Return on Equity (ROE)	-31.70%	-34.70%	-12.10%	-2.90%	-19.80%	0.40%
Return on Assets (ROA)	-20.40%	-22.60%	-9.20%	-2.00%	-13.30%	0.30%
Return on Capital (ROIC)	-25.71%	-27.52%	-13.64%	-17.97%	-19.10%	13.22%
Earnings Yield	-9.98%	-16.74%	-9.53%	-1.23%	-23.60%	0.23%
FCF Yield	-6.58%	-11.71%	-12.89%	0.03%	5.97%	3.68%
Buyback Yield / Dilution	-10.58%	-2.73%	-3.33%	-4.98%	2.24%	-5.56%
Total Shareholder Return	-10.58%	-2.73%	-3.33%	-4.98%	2.24%	-5.56%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).